HAB Pharma, Signature Phytochemicals merge to form Rs. 600 crore integrated pharma entity
Combined company targets Rs. 2,500–3,000 crore revenue by 2030; new sterile and OSD plants to begin operations by August 2026
Combined company targets Rs. 2,500–3,000 crore revenue by 2030; new sterile and OSD plants to begin operations by August 2026
The global pharmaceutical company has been featured in both the DJBIC World Index and the DJBIC Emerging Markets Index
The move signals a strategic pivot toward deeper integration between clinical leadership and medical technology developers
We are building an AI-native operating system for pharma sales and distribution
Healthcare operations veteran with over 23 years of experience to lead key initiatives across South India
The event will bring together industrial leaders, technology providers, and policymakers to discuss real-world Industrial AI applications in Bangalore
Conceptualized as an aggregator platform it integrates existing programme systems through an API-based federated architecture
Enterprise-scale adoption in 2026 will be driven by domain-specific AI, compliance automation, and strong digital foundations across quality, manufacturing and regulatory workflows
Week-long Fire Safety Week 2026 campaign focuses on strengthening fire prevention, preparedness, audits, and emergency response across hospitals and healthcare facilities
Rahul Bhatnagar succeeds Aditya Narayan, who completed a decade-long distinguished tenure
Subscribe To Our Newsletter & Stay Updated